Applied Genetic Technologies Corporation
AGTC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12 | $35 | $47 | $81 |
| - Cash | $34 | $46 | $68 | $73 |
| + Debt | $20 | $22 | $25 | $22 |
| Enterprise Value | -$2 | $11 | $3 | $31 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | – |
| EBITDA | -$17 | -$17 | -$13 | -$18 |
| % Margin | – | -5,335.7% | – | – |
| Net Income | $17 | -$19 | -$15 | -$18 |
| % Margin | – | -5,837.5% | – | – |
| EPS Diluted | 0.38 | -0.42 | -0.34 | -0.43 |
| % Growth | 190.5% | -23.5% | 20.9% | – |
| Operating Cash Flow | -$17 | -$18 | -$14 | $0 |
| Capital Expenditures | -$0 | -$1 | -$0 | -$1 |
| Free Cash Flow | -$18 | -$19 | -$14 | -$1 |